Logo

American Heart Association

  20
  0


Final ID: MP445

Group Virtual Care for Women with Cardiovascular-Kidney-Metabolic Syndrome: Engagement and Lifestyle Change in a Scalable Model

Abstract Body (Do not enter title and authors here): Introduction: Cardiovascular-kidney-metabolic (CKM) syndrome is a growing public health challenge marked by rising morbidity, mortality, and healthcare costs. Traditional care models often struggle to engage patients, with no-show rates reaching 18–20%. Scalable strategies to engage at-risk patients are urgently needed.

Objective: To assess the impact of a group virtual care model on engagement, experience, and lifestyle behavior change in CKM.

Methods: Systole Health, a virtual group care organization, enrolled cohorts of 3–5 women into a six-week CKM optimization program across 16 U.S. states between April 2024 and March 2025. Eligible participants had documented or self-reported overweight/obesity, hypertension (HTN), dyslipidemia (DLD), and/or (pre)diabetes. Exclusion criteria included active pregnancy and unstable CKM. The intervention included weekly cardiologist-led shared medical appointments, lifestyle health coaching, medication optimization, and coach-led group and individual text support. Attendance was tracked, and satisfaction and self-reported behavior change were assessed via post-program surveys. Linear regression evaluated associations between attendance and changes in BMI, blood pressure, and LDL cholesterol.

Results: A total of 45 women enrolled, contributing 247 patient visits. Mean age was 52.2 ± 11.5 years; 86.7% were White. Most participants (53.3%) had ≥3 CKM risk factors (BP ≥130/80, LDL-C above guideline-recommended thresholds, BMI ≥27, and/or A1c ≥5.7%); overall, 88.9% had overweight/obesity, 35.6% HTN, 44.4% DLD, and 24.4% (pre)diabetes. Median attendance was 6 of 6 sessions (interquartile range [IQR] 1), with a program completion rate (≥5 sessions) of 85.1%. Median satisfaction and likelihood to recommend were both 10/10 (IQRs 0.5 and 0.25, respectively). Participants reported improvements in heart health understanding (100.0%), medication knowledge (91.7%), motivation to monitor health data (95.8%), confidence preparing for medical visits (87.5), sense of support (100.0%), nutrition (87.6%), cardiovascular exercise (83.3%), and overall health (87.5) (Figure 1). Clinical outcomes trended favorably with higher attendance, though associations were not statistically significant.

Conclusion: A group virtual care model for women with CKM risk factors demonstrated high engagement, satisfaction, and self-reported behavior change, supporting its potential as a scalable, patient-centered strategy for CKM care.
  • Parmar, Sehej-leen  ( Harvard Medical School , Boston , Massachusetts , United States )
  • Cannon, Christopher  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Lee, Simin  ( Systole Health , Boston , Massachusetts , United States )
  • Author Disclosures:
    Sehej-leen Parmar: DO NOT have relevant financial relationships | Christopher Cannon: DO have relevant financial relationships ; Consultant:Chiesi, Amgen, Ascendia, Biogen, BI, BMS, CSL Behring, Genomadix, Lilly, Janssen, Lexicon, Milestone, Novartis, Pfizer, Rhoshan:Active (exists now) ; Research Funding (PI or named investigator):Amgen, Bayer, Cleerly, Esperion, Lexicon, Silence:Active (exists now) ; Research Funding (PI or named investigator):Amgen, Better Therapeutics, Boehringer-Ingelheim (BI), Novo Nordisk:Active (exists now) | Simin Lee: DO have relevant financial relationships ; Executive Role:Systole Health:Active (exists now) ; Ownership Interest:Systole Health:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

CKM Syndrome Care and Outcomes Among Women and Young Adults

Saturday, 11/08/2025 , 12:15PM - 01:30PM

Moderated Digital Poster Session

More abstracts on this topic:
More abstracts from these authors:
Closing Prevention Gaps in Women’s Heart Health: Real-World Impact of a Scalable Group Virtual Care Model

Parmar Sehej-leen, Lee Simin, Lau Emily

EVOLocumab Very Early after Myocardial Infarction (EVOLVE-MI): A Pragmatic Randomized Multicenter International Trial - Design and Baseline Characteristics

Bonaca Marc, Wang Huei, Wu You, Cyrille Marcoli, Cannon Christopher, Hess Connie, Tavares Caio, James Stefan, Oldgren Jonas, Bhatt Deepak, Abbott Jinnette, Mehran Roxana, Berwanger Otavio

You have to be authorized to contact abstract author. Please, Login
Not Available